The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Viridian Therapeutics Inc (NASDAQ: VRDN) was $23.66 for the day, up 2.82% from the previous closing price of $23.01. In other words, the price has increased by $2.82 from its previous closing price. On the day, 1.26 million shares were traded. VRDN stock price reached its highest trading level at $24.23 during the session, while it also had its lowest trading level at $23.0.
Ratios:
Our analysis of VRDN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.01 and its Current Ratio is at 11.01. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 19, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $37 to $27.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 23 ’25 when Fairmount Funds Management LLC bought 454,545 shares for $22.00 per share. The transaction valued at 9,999,990 led to the insider holds 3,914,458 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 2202581248 and an Enterprise Value of 1580741632. For the stock, the TTM Price-to-Sale (P/S) ratio is 7341.93 while its Price-to-Book (P/B) ratio in mrq is 5.92. Its current Enterprise Value per Revenue stands at 5182.76 whereas that against EBITDA is -4.26.
Stock Price History:
The Beta on a monthly basis for VRDN is 0.78, which has changed by 0.061939 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, VRDN has reached a high of $27.20, while it has fallen to a 52-week low of $9.90. The 50-Day Moving Average of the stock is 15.08%, while the 200-Day Moving Average is calculated to be 41.12%.
Shares Statistics:
VRDN traded an average of 999.73K shares per day over the past three months and 1927810 shares per day over the past ten days. A total of 93.09M shares are outstanding, with a floating share count of 83.85M. Insiders hold about 9.93% of the company’s shares, while institutions hold 94.08% stake in the company. Shares short for VRDN as of 1760486400 were 9986922 with a Short Ratio of 9.99, compared to 1757894400 on 11000468. Therefore, it implies a Short% of Shares Outstanding of 9986922 and a Short% of Float of 12.770000000000001.
Earnings Estimates
Current recommendations for the stock of the company come from 11.0 analysts. The consensus estimate for the next quarter is -$1.06, with high estimates of -$0.42 and low estimates of -$1.36.
Analysts are recommending an EPS of between -$2.96 and -$4.97 for the fiscal current year, implying an average EPS of -$4.05. EPS for the following year is -$3.91, with 11.0 analysts recommending between -$2.9 and -$4.99.
